Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: SATURDAY, March 31, 1990 TAG: 9003310346 SECTION: NATIONAL/INTERNATIONAL PAGE: A2 EDITION: METRO SOURCE: DATELINE: WASHINGTON LENGTH: Short
The drug, a steroid often used to treat symptoms of shock and to prevent swelling after strokes or surgery, appears to halt deterioration of spinal cord cells and tissue, according to study results announced by the National Institute of Neurological Disorders and Stroke.
Before the study, "the whole field had been absolutely dismal with no hope of improving the fate of the patient," said Dr. Phanor L. Perot Jr., chairman of the department of surgery of the Yale University School of Medicine and one of the study researchers. "This study gives concrete proof . . . that we can stop the lethal process." - Los Angeles Times
by CNB